COMMUNIQUÉS West-GlobeNewswire

Lirum Therapeutics Presents Positive Data on LX-101 at the 2025 ESMO Targeted Anticancer Therapies Congress; Highlighting LX-101’s Promise in IGF-1R Prominent Cancers

04/03/2025 - 16:30

New York, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the [...]

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

04/03/2025 - 16:00

ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care , a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an [...]

Verana Health Enhances Site Explorer Tool to Advance Diversity in Clinical Trials

04/03/2025 - 16:00

Exclusive data access and expanded functionality allows trial sponsors and contract research organizations (CROs) to enhance inclusive representation, improve clinical trial enrollment, and strengthen evidence SAN [...]

Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor

04/03/2025 - 16:00

TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. [...]

H.H.C. Group Highlights Flat-Fee Approach to Dialysis Claim Review, Unveils Cost-Saving Case Study for March Kidney Month

04/03/2025 - 15:58

ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Recognizing March as National Kidney Month , H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim [...]

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

04/03/2025 - 15:15

Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted [...]

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

03/03/2025 - 22:48

MELBOURNE, Australia and INDIANAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company’s late-stage [...]

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results

03/03/2025 - 22:45

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17 after the markets close. FibroGen will also conduct a [...]

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

03/03/2025 - 22:35

SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed receipt of a non-binding proposal [...]

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

03/03/2025 - 22:35

Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients [...]

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03/03/2025 - 22:30

MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

03/03/2025 - 22:30

PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository [...]

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

03/03/2025 - 22:30

TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor [...]

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

03/03/2025 - 22:30

Nyxoah to Participate in the Oppenheimer 35 th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – March 3, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]

Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech & Services Conference

03/03/2025 - 22:30

Nyxoah Participera à la 35 ème Oppenheimer Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgique – 3 mars 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » [...]

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

03/03/2025 - 22:23

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 [...]

Tenaya Therapeutics Announces Proposed Public Offering

03/03/2025 - 22:10

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]

Amwell makes inducement grant

03/03/2025 - 22:05

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares [...]

Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

03/03/2025 - 22:05

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 [...]